Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Siebert

Showing results (31-40 of 359) with videos related to

Pageof 36
Sort By:
BMC Cancer|June 26, 2023
Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutationsLára R Hallsson, Gaby Sroczynski, Jutta Engel, et al.
BMC Health Services Research|April 21, 2017
Personalized medicine in Europe: not yet personal enough?Antonello Di Paolo, François Sarkozy, Bettina Ryll, et al.
Journal of the American Medical Informatics Association : JAMIA|June 27, 2008
The effect of electronic prescribing on medication errors and adverse drug events: a systematic reviewElske Ammenwerth, Petra Schnell-Inderst, Christof Machan, et al.
GMS Health Technology Assessment|February 4, 2011
Orchiectomy versus medical therapy with LH-RH analogues for the treatment of advanced prostatic carcinomaVolker Rohde, Kristin Grabein, Franz Hessel, et al.
Applied Health Economics and Health Policy|February 11, 2017
Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic ReviewIrmgard C Schiller-Frühwirth, Beate Jahn, Marjan Arvandi, et al.
Plos One|March 4, 2016
Real-World Use of 3rd Line Therapy for Multiple Myeloma in Austria: An Austrian Myeloma Registry (AMR) Analysis of the Therapeutic Landscape and Clinical Outcomes prior to the Use of Next Generation Myeloma TherapeuticsElla Willenbacher, Roman Weger, Ursula Rochau, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 3, 2026
Factors associated with health state valuations: a secondary analysis of an EQ-5D-3L valuation study from JordanAbeer Al Rabayah, Fatima Al Sayah, Marjan Arvandi, et al.
Journal of Personalized Medicine|December 23, 2015
Assessing the Costs and Cost-Effectiveness of Genomic SequencingKurt D Christensen, Dmitry Dukhovny, Uwe Siebert, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 15, 2022
Determinants of willingness to pay for health services: a systematic review of contingent valuation studiesCaroline Steigenberger, Magdalena Flatscher-Thoeni, Uwe Siebert, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|December 22, 2018
Cost utility of fractional flow reserve-guided percutaneous coronary intervention in multivessel coronary artery disease in BrazilSteffan Frosi Stella, Carísi Anne Polanczyk, Marjan Arvandi, et al.
Pageof 36

Showing results (31-40 of 359) with videos related to

Sort By:
Pageof 36
BMC Cancer|June 26, 2023
Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutationsLára R Hallsson, Gaby Sroczynski, Jutta Engel, et al.
BMC Health Services Research|April 21, 2017
Personalized medicine in Europe: not yet personal enough?Antonello Di Paolo, François Sarkozy, Bettina Ryll, et al.
Journal of the American Medical Informatics Association : JAMIA|June 27, 2008
The effect of electronic prescribing on medication errors and adverse drug events: a systematic reviewElske Ammenwerth, Petra Schnell-Inderst, Christof Machan, et al.
GMS Health Technology Assessment|February 4, 2011
Orchiectomy versus medical therapy with LH-RH analogues for the treatment of advanced prostatic carcinomaVolker Rohde, Kristin Grabein, Franz Hessel, et al.
Applied Health Economics and Health Policy|February 11, 2017
Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic ReviewIrmgard C Schiller-Frühwirth, Beate Jahn, Marjan Arvandi, et al.
Plos One|March 4, 2016
Real-World Use of 3rd Line Therapy for Multiple Myeloma in Austria: An Austrian Myeloma Registry (AMR) Analysis of the Therapeutic Landscape and Clinical Outcomes prior to the Use of Next Generation Myeloma TherapeuticsElla Willenbacher, Roman Weger, Ursula Rochau, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 3, 2026
Factors associated with health state valuations: a secondary analysis of an EQ-5D-3L valuation study from JordanAbeer Al Rabayah, Fatima Al Sayah, Marjan Arvandi, et al.
Journal of Personalized Medicine|December 23, 2015
Assessing the Costs and Cost-Effectiveness of Genomic SequencingKurt D Christensen, Dmitry Dukhovny, Uwe Siebert, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|February 15, 2022
Determinants of willingness to pay for health services: a systematic review of contingent valuation studiesCaroline Steigenberger, Magdalena Flatscher-Thoeni, Uwe Siebert, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|December 22, 2018
Cost utility of fractional flow reserve-guided percutaneous coronary intervention in multivessel coronary artery disease in BrazilSteffan Frosi Stella, Carísi Anne Polanczyk, Marjan Arvandi, et al.
Pageof 36